HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation

BS Sheffield, J Garratt, SE Kalloger… - … of Pathology and …, 2014 - meridian.allenpress.com
Context Immunohistochemical (IHC) testing for HER2/neu is becoming the standard of care
for guiding adjuvant treatment of gastric carcinoma with trastuzumab. Objective To assess …
被引用次数：51 相关文章
[PDF] academia.edu

[PDF][PDF] HER2/neu Testing in Gastric Cancer by Immunohistochemistry

BS Sheffield, RT John Garratt, SE Kalloger… - Arch Pathol Lab …, 2014 - academia.edu
Conclusions.—There is substantial interlaboratory agreement in the interpretation of
HER2/neu IHC despite variability in protocols. Although HER2/neu IHC is a highly sensitive …

HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory Variation

BS Sheffield, J Garratt, SE Kalloger… - Archives of Pathology …, 2014 - go.gale.com
Context.--Immunohistochemical (IHC) testing for HER2/neu is becoming the standard of care
for guiding adjuvant treatment of gastric carcinoma with trastuzumab. Objective.--To assess …

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation

BS Sheffield, J Garratt, SE Kalloger… - … of pathology & …, 2014 - pubmed.ncbi.nlm.nih.gov
Context Immunohistochemical (IHC) testing for HER2/neu is becoming the standard of care
for guiding adjuvant treatment of gastric carcinoma with trastuzumab. Objective To assess …

HER2/neu testing in gastric cancer by immunohistochemistry: assessment of interlaboratory variation.

BS Sheffield, J Garratt, SE Kalloger… - Archives of Pathology …, 2014 - europepmc.org
Design A tissue microarray consisting of 45 cores from 28 gastric cancers was distributed to
37 laboratories for HER2/neu assessment. The IHC results were compared against expert …

[引用][C] HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory Variation

BS Sheffield, J Garratt, SE Kalloger… - Archives of Pathology & …, 2014 - cir.nii.ac.jp
HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory
Variation | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory Variation

BS Sheffield, HH Li-Chang… - … of Pathology & …, 2014 - search.proquest.com
Abstract Context.-Immunohistochemical (IHC) testing for HER2/neu is becoming the
standard of care for guiding adjuvant treatment of gastric carcinoma with trastuzumab …
[PDF] researchgate.net

[PDF][PDF] HER2/neu Testing in Gastric Cancer by Immunohistochemistry

BS Sheffield, RT John Garratt, SE Kalloger… - Arch Pathol Lab …, 2014 - researchgate.net
Conclusions.—There is substantial interlaboratory agreement in the interpretation of
HER2/neu IHC despite variability in protocols. Although HER2/neu IHC is a highly sensitive …

HER2/neu Testing in Gastric Cancer by Immunohistochemistry: Assessment of Interlaboratory Variation.

BS Sheffield, J Garratt, SE Kalloger… - … of Pathology & …, 2014 - search.ebscohost.com
Abstract Context.—Immunohistochemical (IHC) testing for HER2/neu is becoming the
standard of care for guiding adjuvant treatment of gastric carcinoma with trastuzumab …
[PDF] academia.edu

[PDF][PDF] HER2/neu Testing in Gastric Cancer by Immunohistochemistry

BS Sheffield, RT John Garratt, SE Kalloger… - Arch Pathol Lab …, 2014 - academia.edu
Conclusions.—There is substantial interlaboratory agreement in the interpretation of
HER2/neu IHC despite variability in protocols. Although HER2/neu IHC is a highly sensitive …